BioAmber slashes proposed range by 31%, includes warrants


Shutterstock photo

BioAmber, which converts renewable feedstocks into bio-succinic acid and other chemicals, lowered the proposed deal size for its upcoming IPO on Tuesday. The Montreal, Canada-based company now plans to raise $88 million by offering 8 million shares at a price range of $10 to $12, along with attached warrants to purchase an 4 million shares at the IPO price. The company had previously filed to offer 8 million shares at a range of $15 to $17. At the midpoint of the revised range, BioAmber will raise 31% fewer proceeds than previously anticipated. BioAmber, which was founded in 2008 and booked $2 million in sales for the 12 months ended 12/31/2012, plans to list on the NYSE under the symbol BIOA and on the Professional Segment of NYSE Euronext in Paris under the symbol BIOA. BioAmber initially filed confidentially on 11/9/2012. Credit Suisse, Societe Generale and Barclays are the joint bookrunners on the deal. 

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines , IPOs

More from Renaissance Capital


Renaissance Capital

Renaissance Capital

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by